Streetbeat News

Equity Actions

CTAS

Cintas Inc. (NASDAQ:CTAS) stock has risen by 9.95% over the past month and 23.72% over the past year, currently trading at $557.59. The stock's P/E ratio of 41.72 is higher than the industry average of 33.12, which could suggest better performance or overvaluation. Investors are advised to consider the P/E ratio alongside other financial metrics and qualitative analysis for investment decisions.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 6:45 pm

ALB

CCI

DIA

DPZ

GDX

IWM

KLC

MELI

QQQ

SPY

TAN

TTD

WOOF

XLE

XLRE

XLY

U.S. stocks saw a slight decline except for tech stocks in the Nasdaq 100, which gained on positive Black Friday online sales data from Adobe and Salesforce. Treasury yields fell, gold prices rose, and oil prices dipped ahead of an oil producers' meeting. Sector-wise, real estate and consumer discretionary stocks performed well, while energy lagged. The Trade Desk, MercadoLibre, and Zoom Video led Nasdaq 100 gains, while Domino's Pizza topped the S&P 500 after a price target raise. Crown Castle rallied on news of a significant investment by Elliott Management. Albemarle Corp., WK Kellog Co, and Petco were among the worst performers. Bond ETFs rose, European indices fell, and cryptocurrencies declined.

Portfolio Pulse from Piero Cingari

November 27, 2023 | 6:14 pm

ELV

Elevance Health (NYSE:ELV) has seen a 3.53% increase in short interest since its last report, with 2.06 million shares sold short, representing 0.88% of available shares. The short interest is below the peer group average of 3.29%. While an increase in short interest can indicate bearish sentiment, it does not necessarily predict a near-term price drop.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 6:00 pm

JPM

Benzinga's options scanner revealed significant options activity for JPMorgan Chase (NYSE:JPM), with a bullish sentiment from deep-pocketed investors. The activity included 11 unusual options trades, with 54% bullish and 45% bearish sentiment. The focus is on a price band between $135.0 and $160.0. The largest options trades were calls, with varying sentiments and expiration dates. JPMorgan Chase, a major financial institution, has a current stock price of $152.88, with indications of being overbought. An analyst from Oppenheimer maintains an Outperform rating with a $243 price target. The next earnings report is expected in 46 days.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 5:30 pm

DDD

There was a notable options trading activity for 3D Systems Corporation, where a sweep of May 17 $7 call options was executed near the ask price, involving 2,292 contracts at $0.5 each compared to an open interest of 110 contracts, with the underlying stock reference price at $5.21.

Portfolio Pulse from Charles Gross

November 27, 2023 | 4:42 pm

KHC

Kraft Heinz Co (NASDAQ:KHC) has announced a new share repurchase program authorized by its Board of Directors, allowing for the buyback of up to $3 billion in shares until December 26, 2026. The company plans to use excess cash for the buybacks after accounting for capital expenditures. CEO Miguel Patricio expressed confidence in the company's strategy and considered its shares to be an attractive investment. The repurchase program is flexible, with no obligation to buy a specific number of shares and can be adjusted or halted at any time. As of September 30, 2023, Kraft Heinz had $1.05 billion in cash and equivalents. Following the news, KHC shares saw a modest increase of 0.49% to $35.11.

Portfolio Pulse from Shivani Kumaresan

November 27, 2023 | 4:01 pm

AZN

AstraZeneca (NASDAQ:AZN) is evaluated against its competitors in the Pharmaceuticals industry. The analysis includes financial metrics like P/E, P/B, P/S ratios, ROE, EBITDA, gross profit, and revenue growth. AstraZeneca's P/E, P/B, and P/S ratios are below the industry average, suggesting potential undervaluation. However, its ROE, EBITDA, gross profit, and revenue growth are also below the industry average, indicating possible inefficiencies and lower profitability. The company's lower debt-to-equity ratio compared to its top 4 peers suggests a stronger financial position.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 4:00 pm

ANSS

Ansys (NASDAQ:ANSS) is analyzed against its software industry peers, revealing it has a lower P/E, P/B, and higher P/S ratios compared to the industry average. Ansys's ROE, EBITDA, gross profit, and revenue growth are below its peers, indicating potential inefficiencies and weaker profitability. The company's lower debt-to-equity ratio suggests a stronger financial position with less reliance on debt financing.

Portfolio Pulse from Benzinga Insights

November 27, 2023 | 4:00 pm

ATOMUSD

Jae Kwon, founder of Cosmos, has proposed a chain split for the Cosmos blockchain, which has led to a 3% drop in the value of ATOM, the network's native token. The proposal comes after the Cosmos community approved proposal 848, which reduces ATOM's inflation from 14% to 10%. Kwon suggests creating AtomOne, a forked chain that would support the existing ATOM token and a new ATOM1 token, to prevent a massive selloff and potential collapse of ATOM.

Portfolio Pulse from Mehab Qureshi

November 27, 2023 | 3:51 pm

ARVN

Arvinas Inc (NASDAQ:ARVN) shares rose 11.2% after announcing a $350 million private placement of common stock and pre-funded warrants. The funds will support clinical programs, preclinical pipeline, and general operations. The placement, co-led by EcoR1 Capital and RTW Investments, LP, is set to close on November 28. BofA Securities, Inc. and Goldman Sachs & Co. LLC were the joint lead placement agents.

Portfolio Pulse from Henry Khederian

November 27, 2023 | 3:47 pm